Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL
SALT LAKE CITY, Feb. 15, 2023. Sera Prognostics Inc., The Pregnancy Company, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced top-line results from the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 15, 2023 Category: Pharmaceuticals Source Type: clinical trials

DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study
Conditions:   Diabetes Mellitus;   Diabetic Kidney Disease;   Hypertension Intervention:   Other: Salt-Diet and/or Ertugliflozin Sponsors:   Amsterdam UMC, location VUmc;   Merck Sharp & Dohme LLC;   University of Colorado, Denver Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2023 Category: Research Source Type: clinical trials

Study for Efficacy and Safety Assessment of the Drug RADAMIN ®VIRO for COVID-19 Postexposure Prophylaxis
Condition:   COVID-19 Interventions:   Drug: Double-Stranded RNA sodium salt;   Drug: Placebo Sponsor:   Promomed, LLC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 10, 2023 Category: Research Source Type: clinical trials